Position in PCVX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$452,542
-$31,804 QoQ
Shares Held
7,785
-6.6% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#199
of 329 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Meeder Advisory Services, Inc. holds $10,646,226 across 17 Biotechnology names. PCVX ranks #8 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,415 | $3,186,522 | |
| 2 | RPRX |
Royalty Pharma plc
|
19,242 | $1,078,898 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,311 | $817,460 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,922 | $734,512 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
7,660 | $607,361 | |
| 6 | MRNA |
Moderna, Inc.
|
7,734 | $541,612 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,611 | $484,959 | |
| 8 | PCVX |
Vaxcyte, Inc.
This page
|
7,785 | $452,542 |
All Filings in PCVX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $452,542 | 7,785 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $484,346 | 8,335 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $373,918 | 8,104 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $209,564 | 5,818 | Shares | Sole | 2025-10-24 | |
| No filing history on record for this holder in this stock. | ||||||